XOMA (STU:X0M1) Receivables Turnover : 2.97 (As of Mar. 2024)

View and export this data going back to 1986. Start your Free Trial

What is XOMA Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. XOMA's Revenue for the three months ended in Mar. 2024 was €1.37 Mil. XOMA's average Accounts Receivable for the three months ended in Mar. 2024 was €0.46 Mil. Hence, XOMA's Receivables Turnover for the three months ended in Mar. 2024 was 2.97.

XOMA Receivables Turnover Historical Data

The historical data trend for XOMA's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XOMA Receivables Turnover Chart

XOMA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Receivables Turnover

Get a 7-Day Free Trial

8.41

16.91

168.44

61.17

9.46

XOMA Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Receivables Turnover	Get a 7-Day Free Trial															116.57	3.65	1.78	3.50	2.97

Competitive Comparison of XOMA's Receivables Turnover

For the Biotechnology subindustry, XOMA's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

XOMA's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, XOMA's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where XOMA's Receivables Turnover falls into.

XOMA Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

XOMA's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

	Receivables Turnover (A: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2023 )	/ (	(Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )
=	4.363	/ (	(0.001	+	0.921)	/	2 )
=	4.363	/	0.461
=	9.46

XOMA's Receivables Turnover for the quarter that ended in Mar. 2024 is calculated as

	Receivables Turnover (Q: Mar. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Mar. 2024 )	/ (	(Accounts Receivable (Q: Dec. 2023 )	+	Accounts Receivable (Q: Mar. 2024 ))	/	count )
=	1.371	/ (	(0.921	+	0.003)	/	2 )
=	1.371	/	0.462
=	2.97

XOMA (STU:X0M1) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

XOMA Receivables Turnover Related Terms

Thank you for viewing the detailed overview of XOMA's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

XOMA (STU:X0M1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XOMA Corp (STU:X0M1) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

XOMAO.PFD:USA XOMAP.PFD:USA XOMA:USA X0M1:Germany

Address

2200 Powell Street, Suite 310, Emeryville, CA, USA, 94608

Website

https://www.xoma.com

XOMA Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

XOMA (STU:X0M1) Headlines

No Headlines